Hiroki Nakatani

704 total citations
14 papers, 468 citations indexed

About

Hiroki Nakatani is a scholar working on General Health Professions, Infectious Diseases and Health. According to data from OpenAlex, Hiroki Nakatani has authored 14 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in General Health Professions, 3 papers in Infectious Diseases and 3 papers in Health. Recurrent topics in Hiroki Nakatani's work include Healthcare Systems and Reforms (3 papers), Global Health Care Issues (2 papers) and Intergenerational Family Dynamics and Caregiving (2 papers). Hiroki Nakatani is often cited by papers focused on Healthcare Systems and Reforms (3 papers), Global Health Care Issues (2 papers) and Intergenerational Family Dynamics and Caregiving (2 papers). Hiroki Nakatani collaborates with scholars based in Japan, Switzerland and Indonesia. Hiroki Nakatani's co-authors include Mario Raviǵlione, Diana Weil, Michel Sidibé, Lorenzo Savioli, Christopher Dye, Gottfried Hirnschall, Tedros Adhanom Ghebreyesus, Robert D. Newman, Michel D. Kazatchkine and T. Mertens and has published in prestigious journals such as The Lancet, Trends in Parasitology and Bulletin of the World Health Organization.

In The Last Decade

Hiroki Nakatani

13 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroki Nakatani Japan 8 138 110 71 71 61 14 468
H Sudarshan India 10 100 0.7× 64 0.6× 111 1.6× 80 1.1× 41 0.7× 13 586
Khaleda Islam Bangladesh 15 61 0.4× 71 0.6× 80 1.1× 39 0.5× 81 1.3× 54 544
Sachin Silva United States 10 191 1.4× 122 1.1× 81 1.1× 155 2.2× 125 2.0× 13 674
Martha Gyansa‐Lutterodt Ghana 13 207 1.5× 60 0.5× 125 1.8× 100 1.4× 53 0.9× 20 550
Pierre Abi Hanna Lebanon 7 241 1.7× 111 1.0× 30 0.4× 149 2.1× 80 1.3× 15 464
Sharmila Sengupta India 13 165 1.2× 180 1.6× 50 0.7× 60 0.8× 173 2.8× 31 559
Anna Durrance‐Bagale United Kingdom 13 130 0.9× 49 0.4× 103 1.5× 64 0.9× 46 0.8× 31 469
Aubrey Chichonyi Kalungia Zambia 12 363 2.6× 117 1.1× 127 1.8× 114 1.6× 53 0.9× 45 651
RD Smith United Kingdom 5 207 1.5× 83 0.8× 59 0.8× 103 1.5× 57 0.9× 7 407
Karin Gallandat United States 12 157 1.1× 74 0.7× 47 0.7× 96 1.4× 179 2.9× 26 665

Countries citing papers authored by Hiroki Nakatani

Since Specialization
Citations

This map shows the geographic impact of Hiroki Nakatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Nakatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Nakatani more than expected).

Fields of papers citing papers by Hiroki Nakatani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Nakatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Nakatani. The network helps show where Hiroki Nakatani may publish in the future.

Co-authorship network of co-authors of Hiroki Nakatani

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Nakatani. A scholar is included among the top collaborators of Hiroki Nakatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Nakatani. Hiroki Nakatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Nakatani, Hiroki, et al.. (2021). Approach of Medical Excellence JAPAN to create platforms of collaboration in Asia. Global Health & Medicine. 3(6). 401–405. 1 indexed citations
3.
Nakatani, Hiroki, et al.. (2020). Global health landscape challenges triggered by COVID-19. Inflammation and Regeneration. 40(1). 34–34. 4 indexed citations
4.
Susilowati, Indri Hapsari, et al.. (2020). COVID-19 handling report for pre-case, case (pre-hospital and hospital), and post-case phases in the elderly as vulnerable populations in 6 Asia Pacific countries. Global Health & Medicine. 2(6). 350–359. 6 indexed citations
5.
6.
Nakatani, Hiroki. (2016). Global Strategies for the Prevention and Control of Infectious Diseases and Non-Communicable Diseases. Journal of Epidemiology. 26(4). 171–178. 11 indexed citations
7.
Dye, Christopher, T. Mertens, Gottfried Hirnschall, et al.. (2013). WHO and the future of disease control programmes. The Lancet. 381(9864). 413–418. 40 indexed citations
8.
Weil, Diana, et al.. (2011). The WHO policy package to combat antimicrobial resistance. Bulletin of the World Health Organization. 89(5). 390–392. 252 indexed citations
9.
Ghebreyesus, Tedros Adhanom, Michel D. Kazatchkine, Michel Sidibé, & Hiroki Nakatani. (2010). Tuberculosis and HIV: time for an intensified response. The Lancet. 375(9728). 1757–1758. 20 indexed citations
10.
Takei, Teiji, Hiroshi Takahashi, & Hiroki Nakatani. (2008). Developing a uniformed assessment tool to evaluate care service needs for disabled persons in Japan. Health Policy. 86(2-3). 373–380. 5 indexed citations
11.
Kasai, Takeshi, Hiroki Nakatani, Tsutomu Takeuchi, & Andy Crump. (2007). Research and control of parasitic diseases in Japan: current position and future perspectives. Trends in Parasitology. 23(5). 230–235. 12 indexed citations
12.
Nakatani, Hiroki & Takefumi Kondo. (2003). Characteristics of a medical care program for specific diseases in Japan in an era of changing cost-sharing. Health Policy. 64(3). 377–389. 10 indexed citations
13.
Nakatani, Hiroki, et al.. (2002). Development of Vaccination Policy in Japan: Current Issues and Policy Directions. Japanese Journal of Infectious Diseases. 55(4). 101–111. 37 indexed citations
14.
Nakatani, Hiroki. (2000). Characteristics of and Evaluation Study on the Medical Care Program for Specific Diseases. 77(4). 143–156. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H Sudarshan Breakdown of academic impact, for papers by Khaleda Islam Breakdown of academic impact, for papers by Sachin Silva Breakdown of academic impact, for papers by Martha Gyansa‐Lutterodt Breakdown of academic impact, for papers by Pierre Abi Hanna Breakdown of academic impact, for papers by Sharmila Sengupta Breakdown of academic impact, for papers by Anna Durrance‐Bagale Breakdown of academic impact, for papers by Aubrey Chichonyi Kalungia Breakdown of academic impact, for papers by RD Smith Breakdown of academic impact, for papers by Karin Gallandat
Rankless by CCL
2026